Description
Samotolisib is an investigational drug currently being studied in clinical trials. It is being investigated for certain types of cancer, including some advanced solid tumors in pediatric patients. The trials are designed to see if targeting specific genetic changes (mutations) in a patient's tumor with this drug can help treat the cancer. It is being studied in combination with other targeted therapies. The specific role of samotolisib in colorectal cancer is still under investigation, and it is not yet an approved treatment for this disease.
Mechanism of Action
Samotolisib is being studied as a targeted therapy. It targets a specific protein involved in cell signaling pathways that can contribute to tumor growth and survival. The specific protein target is being characterized in clinical trials. It is designed to block the activity of this protein, potentially slowing or stopping cancer cell growth.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.